174 related articles for article (PubMed ID: 7723404)
1. Interferon-gamma inhibits apoptosis induced by wild-type p53, cytotoxic anti-cancer agents and viability factor deprivation in myeloid cells.
Lotem J; Sachs L
Leukemia; 1995 Apr; 9(4):685-92. PubMed ID: 7723404
[TBL] [Abstract][Full Text] [Related]
2. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells.
Gottlieb E; Lindner S; Oren M
Cell Growth Differ; 1996 Mar; 7(3):301-10. PubMed ID: 8838860
[TBL] [Abstract][Full Text] [Related]
3. p53-independent apoptosis induced by genistein in lung cancer cells.
Lian F; Li Y; Bhuiyan M; Sarkar FH
Nutr Cancer; 1999; 33(2):125-31. PubMed ID: 10368806
[TBL] [Abstract][Full Text] [Related]
4. Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways.
Lotem J; Sachs L
Cell Growth Differ; 1994 Mar; 5(3):321-7. PubMed ID: 7517174
[TBL] [Abstract][Full Text] [Related]
5. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
Altura RA; Inukai T; Ashmun RA; Zambetti GP; Roussel MF; Look AT
Blood; 1998 Aug; 92(4):1397-405. PubMed ID: 9694729
[TBL] [Abstract][Full Text] [Related]
6. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
[TBL] [Abstract][Full Text] [Related]
7. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
8. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes.
Lotem J; Sachs L
Leukemia; 1996 Jun; 10(6):925-31. PubMed ID: 8667646
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
Ramondetta L; Mills GB; Burke TW; Wolf JK
Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
[TBL] [Abstract][Full Text] [Related]
10. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
11. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells.
Shao ZM; Dawson MI; Li XS; Rishi AK; Sheikh MS; Han QX; Ordonez JV; Shroot B; Fontana JA
Oncogene; 1995 Aug; 11(3):493-504. PubMed ID: 7630633
[TBL] [Abstract][Full Text] [Related]
12. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-colony stimulating factor induced apoptosis in radiation-induced murine leukemia cell line.
Handa A; Kashimura T; Kawano N; Yamamoto A; Yoshida S; Jinnai I; Murohashi I; Bessho M; Hirashima K
Leukemia; 1997 Apr; 11 Suppl 3():387-8. PubMed ID: 9209400
[TBL] [Abstract][Full Text] [Related]
14. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool.
Luo JL; Yang Q; Tong WM; Hergenhahn M; Wang ZQ; Hollstein M
Oncogene; 2001 Jan; 20(3):320-8. PubMed ID: 11313961
[TBL] [Abstract][Full Text] [Related]
15. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
16. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
17. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
Burns TF; Bernhard EJ; El-Deiry WS
Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 beta-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells.
Kondo S; Barna BP; Morimura T; Takeuchi J; Yuan J; Akbasak A; Barnett GH
Cancer Res; 1995 Dec; 55(24):6166-71. PubMed ID: 8521409
[TBL] [Abstract][Full Text] [Related]
19. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
Amanullah A; Liebermann DA; Hoffman B
Oncogene; 2000 Jun; 19(26):2967-77. PubMed ID: 10871848
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells.
Srivastava P; Russo J; Mgbonyebi OP; Russo IH
Anticancer Res; 1998; 18(6A):4003-10. PubMed ID: 9891438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]